Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.96 | N/A |
| PEG Ratio (TTM) | 1.29 | N/A |
| P/S Ratio (TTM) | 0.78 | N/A |
| P/B Ratio (TTM) | 1.16 | N/A |
| P/FCF Ratio (TTM) | 4.64 | N/A |
| Price to 5YR AVG Earnings Ratio | 11.51 | N/A |
| Price to 5YR AVG FCF Ratio | 17.91 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.37% | N/A |
| ROE (TTM) | 7.91% | N/A |
| Net Profit Margin (TTM) | 5.20% | N/A |
| ROIC 5YR AVG | 12.15% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 21.61% | 66.65% | 25.76% |
| Revenue | -1.44% | 22.96% | 10.59% |
| Net Income | 22.11% | 62.31% | 23.06% |
| Cash Flow | 47,425.92% | -0.47% | 254.67% |
Health (72%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.45 | N/A |
| Quick Ratio (TTM) | 1.41 | N/A |
| D/E Ratio (TTM) | 0.17 | N/A |
| Interest Coverage (TTM) | 6.67 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 4.33 | N/A |
| LTL to 5YR AVG FCF | 4.70 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.99% | N/A |